Georgian Diabetes Center

Tbilisi 0159

0 studies enrolling now · 2 studies all time

What they study most

Diabetes

Studies at this site

• Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes — Completed
• ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study — Status unconfirmed